Assessing the role of ADAM10 in Trastuzumab treatment and resistance
<p>Overexpression of the HER2 receptor occurs in about 15-20% of all breast cancers and is correlated with poor prognosis. Trastuzumab (Herceptin®), a monoclonal antibody targeting HER2, was shown to prolong survival of these patients. However, primary or acquired resistance remains a drawback...
主要作者: | Feldinger, K |
---|---|
其他作者: | Kong, A |
格式: | Thesis |
語言: | English |
出版: |
2012
|
主題: |
相似書籍
-
Functional organisation of the Hrd1 ubiquitin ligase complex and its role in ERAD
由: Schulz, J
出版: (2013) -
The role and regulation of Asterless in the centrosome cycle
由: Novak, ZA
出版: (2014) -
Characterisation of AEBP2: a polycomb repressive complex 2 component
由: Grijzenhout, A
出版: (2013) -
Cell stress response and hypoxia in breast cancer
由: Milani, M, et al.
出版: (2011) -
Nitric oxide: a chemical effector of pathogenesis in magnaporthe oryzae
由: Johnson, J
出版: (2011)